Illumina Dividend
Dividend criteria checks 0/6
Illumina does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 0.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$7.29 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Calculating The Fair Value Of Illumina, Inc. (NASDAQ:ILMN)
Apr 26
Revenues Not Telling The Story For Illumina, Inc. (NASDAQ:ILMN)
Mar 20Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition
Feb 23Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Jan 26Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024
Jan 19Investors Appear Satisfied With Illumina, Inc.'s (NASDAQ:ILMN) Prospects As Shares Rocket 40%
Dec 21Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?
Dec 03Would Illumina (NASDAQ:ILMN) Be Better Off With Less Debt?
Oct 24Is There An Opportunity With Illumina, Inc.'s (NASDAQ:ILMN) 40% Undervaluation?
Oct 03At US$167, Is Illumina, Inc. (NASDAQ:ILMN) Worth Looking At Closely?
Aug 22The Big Trends: New Frontiers in Healthcare
Jul 13
Estimating The Intrinsic Value Of Illumina, Inc. (NASDAQ:ILMN)
Jul 03Illumina (NASDAQ:ILMN) Is Carrying A Fair Bit Of Debt
Jun 13Is It Time To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Apr 12Is Illumina (NASDAQ:ILMN) Using Too Much Debt?
Mar 14Are Investors Undervaluing Illumina, Inc. (NASDAQ:ILMN) By 38%?
Dec 30Should You Investigate Illumina, Inc. (NASDAQ:ILMN) At US$221?
Dec 02These 4 Measures Indicate That Illumina (NASDAQ:ILMN) Is Using Debt Reasonably Well
Oct 27Illumina, GenoScreen collaborate on genomic testing for drug-resistant TB
Oct 18Illumina in research collaboration with AstraZeneca on drug target discovery
Oct 11Illumina Engages Obama To Push Its Customers' Reimbursement Agenda
Sep 29Illumina to appeal EU decision to block GRAIL acquisition
Sep 06Illumina Needs Grail, But May Lose It
Aug 30Illumina added to positive catalyst watch at Citi despite Q2 miss
Aug 22Illumina up 9% following drop after Q2 earnings
Aug 15Is It Too Late To Consider Buying Illumina, Inc. (NASDAQ:ILMN)?
Aug 08Still Avoiding Illumina Stock
Aug 05Illumina, Grail deal unlikely to get EU nod – Reuters
Jul 27Is Illumina, Inc. (NASDAQ:ILMN) Trading At A 48% Discount?
Jul 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ILMN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ILMN's dividend payments have been increasing.
Dividend Yield vs Market
| Illumina Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ILMN) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Life Sciences) | 0.4% |
| Analyst forecast in 3 Years (ILMN) | 0% |
Notable Dividend: Unable to evaluate ILMN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ILMN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ILMN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ILMN has not reported any payouts.